newsfilter
← Latest News
GlobeNewswire·

Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting

DEVON, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) (the "Company"), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan